EMILY STEM: Open Payments
NPI 1457993263 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 20 payments from 9 companies in 2025. Trend: 2023 $382 · 2024 $525 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 7 | $161 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 3 | $58 |
| Exeltis, USA Inc. | 2 | $37 |
| PFIZER INC. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| CooperSurgical, Inc. | 1 | $24 |
| Seqirus USA Inc | 1 | $15 |
| MILLICENT US INC | 1 | $14 |
Products named: ZURZUVAE, Qelbree, Veozah, SLYND, PREVNAR 20, Lynkuet, Paragard T 380A, Fluad.
Industry payments across MD — which companies pay providers there.
